Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes-Reference-Cited by-同舟云学术

Safety and tolerability of once‐weekly GLP‐1 receptor agonists in type 2 diabetes

Published:2020-09 Issue:S1 Volume:45 Page:43-60
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Trujillo Jennifer¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Aurora CO USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13225

Reference77 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future

3. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD);Buse JB;Diabetes Care,2018

4. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

5. Burden of Illness in Type 2 Diabetes Mellitus

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

2. Contemporary Management of Obesity: A Comparison of Bariatric Metabolic Surgery and Novel Incretin Mimetic Drugs;Diabetes Technology & Therapeutics;2024-09-01

3. Newer Outpatient Diabetes Therapies and Technologies;Medical Clinics of North America;2024-09

4. What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?;Neurology;2024-08-27

5. The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database;Journal of Endocrinological Investigation;2024-08-14